Predict your next investment

Clayton Dubilier & Rice company logo
Private Equity
FINANCIAL | Investment Firms & Funds
cdr-inc.com

See what CB Insights has to offer

Investments

65

Portfolio Exits

37

Funds

22

Partners & Customers

2

Service Providers

3

About Clayton Dubilier & Rice

Clayton, Dubilier & Rice is a private equity firm specializing in buyouts, acquisitions, and growth capital financings of mature and underperforming companies. It invests in the manufacturing, healthcare, distribution, services, information technology, chemicals, business services, energy services, new materials, industrial automation, industrial properties and services, and consumer goods sectors.

Clayton Dubilier & Rice Headquarter Location

375 Park Avenue 18th Floor

New York, New York, 10152,

United States

212-407-5200

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Clayton Dubilier & Rice Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Clayton Dubilier & Rice Rank

Latest Clayton Dubilier & Rice News

Buyout firms tee up bids for Boots amid online buying shift

Jan 14, 2022

Advent International and KKR are among private equity firms studying potential bids for the international drugstore business being sold by Walgreens Boots Alliance, according to people familiar with the matter. The Boots business is also attracting initial interest from Clayton Dubilier & Rice, the buyout firm that owns British grocer Wm Morrison Supermarket, as well as Apollo Global Management, the people said. The unit, which mostly operates pharmacies in the UK, could be valued at as much as £7bn (€8.4bn) in a sale. Bain Capital and CVC Capital Partners have teamed up as they consider making a joint offer for Boots, the people said, asking not to be identified discussing confidential information. Walgreens could kick off a sale process as soon as the coming weeks, the people said. Boots runs a chain of roughly 2,200 stores in the UK that includes brands such as No7 Beauty Co. It operates 89 outlets in Ireland as well as stores in Norway, the Netherlands and Thailand. Its optician business and a suite of private-label beauty and personal-care brands could also be included in the sale, one of the people said. Read More Sign Up Mr Pessina remains the chairman and largest shareholder of Walgreens. As recently as 2019, he’d been reviewing a deal to take the company private amid interest from, once more, KKR. This raised the rare prospect of a private equity firm buying the same asset a second time. Boots is likely to appeal to a small crop of suitors, with the British high street already struggling before the added impact of pandemic lockdowns. Potential bidders are in the early stages of evaluating the business, and there’s no certainty they will proceed with formal offers, according to the people. Sky News reported earlier that Bain and CVC had teamed up for a potential bid, citing unidentified people. Representatives for Advent, Apollo, Bain, CD&R, CVC, KKR and Walgreens declined to comment. Walgreens Chief Executive Officer Rosalind Brewer said at the JPMorgan Healthcare Conference this week that the company had begun a strategic review of Boots, in line with a move to optimise its portfolio and transform itself into a health care-focused group. The company has been shifting toward expanding into other healthcare markets in recent months, as drugstores face increased competitive pressure from Amazon and other online retailers. In October, it agreed to invest $5.2bn in primary-care provider VillageMD, doubling its stake in the company. The business is part of Walgreens’ international segment, which accounted for about 16pc of the company’s 2021 revenue.

Clayton Dubilier & Rice Investments

65 Investments

Clayton Dubilier & Rice has made 65 investments. Their latest investment was in M2Gen as part of their Private Equity on March 3, 2021.

CBI Logo

Clayton Dubilier & Rice Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/17/2021

Private Equity

M2Gen

$100M

Yes

2

7/23/2020

Private Equity

Cheney Brothers

Yes

4

5/29/2020

PIPE

SIG

$105.01M

Yes

1

5/1/2020

PIPE

Subscribe to see more

$99M

Subscribe to see more

10

11/1/2019

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/17/2021

7/23/2020

5/29/2020

5/1/2020

11/1/2019

Round

Private Equity

Private Equity

PIPE

PIPE

Series C

Company

M2Gen

Cheney Brothers

SIG

Subscribe to see more

Subscribe to see more

Amount

$100M

$105.01M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

4

1

10

10

Clayton Dubilier & Rice Portfolio Exits

37 Portfolio Exits

Clayton Dubilier & Rice has 37 portfolio exits. Their latest portfolio exit was Sirius Computer Solutions on October 18, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/18/2021

Acquired

$99M

5

7/23/2021

IPO

$99M

1

7/6/2021

Acq - Fin - II

$99M

16

4/15/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

3/4/2021

Acquired - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/18/2021

7/23/2021

7/6/2021

4/15/2021

3/4/2021

Exit

Acquired

IPO

Acq - Fin - II

IPO

Acquired - II

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

5

1

16

10

10

Clayton Dubilier & Rice Acquisitions

63 Acquisitions

Clayton Dubilier & Rice acquired 63 companies. Their latest acquisition was Morrisons on October 27, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/27/2021

$99M

Take Private

8

10/19/2021

$99M

Acquired Unit - Fin

2

10/8/2021

Series E+

$99M

$1,041M

Take Private

13

7/2/2021

Subscribe to see more

$99M

Subscribe to see more

10

7/2/2021

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/27/2021

10/19/2021

10/8/2021

7/2/2021

7/2/2021

Investment Stage

Series E+

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$1,041M

Note

Take Private

Acquired Unit - Fin

Take Private

Subscribe to see more

Subscribe to see more

Sources

8

2

13

10

10

Clayton Dubilier & Rice Fund History

22 Fund Histories

Clayton Dubilier & Rice has 22 funds, including Clayton, Dubilier & Rice Fund XI.

Closing Date

Fund

Fund Type

Status

Amount

Sources

3/16/2021

Clayton, Dubilier & Rice Fund XI

$16,000M

5

12/2/2020

CD&R Mercury Parent

$64.9M

1

4/19/2017

Clayton Dubilier & Rice Fund X

Buyouts & Acquisitions

Closed

$10,000M

2

2/27/2014

Clayton Dubilier & Rice Fund IX

Subscribe to see more

Subscribe to see more

$99M

10

12/31/2009

Clayton Dubilier & Rice Fund VIII LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

3/16/2021

12/2/2020

4/19/2017

2/27/2014

12/31/2009

Fund

Clayton, Dubilier & Rice Fund XI

CD&R Mercury Parent

Clayton Dubilier & Rice Fund X

Clayton Dubilier & Rice Fund IX

Clayton Dubilier & Rice Fund VIII LP

Fund Type

Buyouts & Acquisitions

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Amount

$16,000M

$64.9M

$10,000M

$99M

$99M

Sources

5

1

2

10

10

Clayton Dubilier & Rice Partners & Customers

2 Partners and customers

Clayton Dubilier & Rice has 2 strategic partners and customers. Clayton Dubilier & Rice recently partnered with Cardinal Health on June 6, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

6/14/2018

Partner

Cardinal Health

United States

Cardinal Health and Clayton, Dubilier & Rice partner to accelerate growth of naviHealth

`` CD&R 's understanding of naviHealth 's business , and their relationships with current and potential customers , will help provide additional value to patients , health systems , and health plans while also allowing Cardinal Health to benefit from future success . ''

2

6/14/2018

Partner

Cardinal Health, and Clayton Holdings

United States

Subscribe to see more

Subscribe to see more

10

Date

6/14/2018

6/14/2018

Type

Partner

Partner

Business Partner

Cardinal Health

Cardinal Health, and Clayton Holdings

Country

United States

United States

News Snippet

Cardinal Health and Clayton, Dubilier & Rice partner to accelerate growth of naviHealth

`` CD&R 's understanding of naviHealth 's business , and their relationships with current and potential customers , will help provide additional value to patients , health systems , and health plans while also allowing Cardinal Health to benefit from future success . ''

Subscribe to see more

Subscribe to see more

Sources

2

10

Clayton Dubilier & Rice Service Providers

17 Service Providers

Clayton Dubilier & Rice has 17 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Take Private

Commercial Bank

Financial Advisor

Cowen

Take Private

Investment Bank

Financial Advisor

Take Private

Investment Bank

Financial Advisor

Service Provider

Cowen

Associated Rounds

Take Private

Take Private

Take Private

Provider Type

Commercial Bank

Investment Bank

Investment Bank

Service Type

Financial Advisor

Financial Advisor

Financial Advisor

Partnership data by VentureSource

Clayton Dubilier & Rice Team

3 Team Members

Clayton Dubilier & Rice has 3 team members, including current Managing Director, Romain Dutartre.

Name

Work History

Title

Status

Romain Dutartre

Managing Director

Current

Benedikt von Schroder

Chief Executive Officer

Former

Christopher Mackenzie

Managing Director

Former

Name

Romain Dutartre

Benedikt von Schroder

Christopher Mackenzie

Work History

Title

Managing Director

Chief Executive Officer

Managing Director

Status

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.